Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA rash appearing on your legs after starting Mounjaro is unsettling, and it's one of the more common skin-related questions our prescribers field. Most of the time, leg rashes linked to tirzepatide are mild and short-lived; occasionally they signal something that needs prompt attention. This page walks through exactly what's known, what the difference looks like in practice, and what the NHS tirzepatide medicines page advises you to do. Mounjaro is a prescription-only medicine, so any change to your treatment based on a skin reaction should always go through the prescriber who issued it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the scenario most people describe: you used your thigh as the injection site, or rotated to the upper leg, and within 24 to 48 hours there's a pink patch, some itching, or a small raised area where the needle went in. That's a localised injection-site reaction. It's listed in the Mounjaro prescribing information as a known and fairly common occurrence, and it usually settles without any treatment in a few days.
The practical fix is simple: rotate your injection sites properly, alternating between the abdomen, thigh and upper arm across doses. If you've been favouring the same spot on the same leg every week, the tissue can become irritated. Using a fresh needle each time and letting the pen reach room temperature before injecting can also reduce local discomfort. Our Mounjaro overview page covers injection technique in more detail if you want a refresher.
What you're looking for is the reaction staying local and fading. If it spreads outward from the injection point, or if an identical-looking reaction appears on a leg you haven't injected recently, that changes the picture, and the section below explains why.
A rash that isn't tied to the injection spot deserves more attention. Some people on tirzepatide report a generalised skin reaction (patchy redness, hives or an itchy raised rash across one or both legs) that isn't sitting over where the pen went in. This can be a mild hypersensitivity response to the medicine itself, and it may appear anywhere from a few hours to a couple of weeks after starting a new dose.
Mild hypersensitivity reactions often settle on their own or with an antihistamine, but you should tell your prescriber rather than managing it silently. They need to know because the right response (keep going, pause, switch sites, monitor) depends on the full picture of your health and your current dose. You can read more about the broader range of Mounjaro skin reactions that have been reported, or the tirzepatide rash page for a more detailed clinical breakdown.
Rashes that spread quickly, feel hot to the touch, blister, or come with any facial swelling or throat tightness are a different matter entirely. Those are signs of a potentially serious allergic reaction and need emergency care immediately. Don't wait to contact your prescriber in that situation, call 999.
Because Mounjaro is a relatively new medicine with Black Triangle status, the MHRA genuinely wants to hear about skin reactions, even ones that seem minor. Reporting through the Yellow Card scheme takes around five minutes and helps build the UK's safety picture for tirzepatide. You can report it yourself as a patient, you don't need your prescriber to do it on your behalf.
If you're a nume patient and something's happened with your skin since your last review, our aftercare team is available seven days a week. You can reach us through the contact page. For anyone researching Mounjaro before starting treatment, it's worth knowing that a clinical review happens before every prescription, the prescriber considers your medical history, any sensitivities, and whether the medicine is appropriate for you. That process applies whether you're starting fresh or restarting after a break.
The cost of private treatment is a reasonable question at this stage too. Our Mounjaro pricing page explains what a transparent all-in price covers, including the clinical review and aftercare that matters precisely when something unexpected like a skin reaction comes up.
To be direct about the decision tree: a small, itchy patch at your injection site on the thigh, call your prescriber at next contact, or sooner if it hasn't started improving after three to four days. A rash spreading across your legs away from any injection site, contact your prescriber the same day. Swelling of the face, lips or tongue, difficulty breathing, or a rash appearing rapidly across large areas of your body, 999 or A&E straight away, and bring your Mounjaro pen so the treating team knows exactly what you've taken.
The skin rash guide on this site covers the full range of presentations in more detail, and this page on rashes from Mounjaro addresses the question from a slightly different angle for people who aren't sure whether their reaction is related to the medicine at all. If you haven't started treatment yet and want to understand the full side-effect profile before you do, your free consultation with one of our prescribers is the right place to have that conversation.
Start your free consultation and speak with a GPhC-registered prescriber who can review your history before any prescription is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.